Concurrent Presence of ALK Rearrangement and MET Mutation in Lung Adenocarcinoma

J Thorac Oncol. 2019 Feb;14(2):e42-e44. doi: 10.1016/j.jtho.2018.10.149.

Authors

Tian Qiu¹, Fanshuang Zhang¹, Weihua Li¹, Lei Guo¹, Jianming Ying²

Affiliations

¹ Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: [email protected].

PMID: 30683300
DOI: 10.1016/j.jtho.2018.10.149

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma / genetics*
Adenocarcinoma / pathology
Aged
Anaplastic Lymphoma Kinase / genetics*
Female
Gene Rearrangement
Humans
Lung Neoplasms / genetics*
Lung Neoplasms / pathology
Mutation
Proto-Oncogene Proteins c-met / genetics*

Substances

ALK protein, human
Anaplastic Lymphoma Kinase
MET protein, human
Proto-Oncogene Proteins c-met